Terug
Dagbereik
€ 565,33
€ 576,51
52-Weeksbereik
€ 356,14
€ 769,98
Volume
360.674
50D / 200D Gem.
€ 647,35
/
€ 635,19
Vorige Slotkoers
€ 578,51
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 43,0 | 0,3 |
| P/B | 28,4 | 2,9 |
| ROE % | 66,2 | 3,7 |
| Net Margin % | 24,6 | 3,8 |
| Rev Growth 5Y % | 7,6 | 10,0 |
| D/E | 0,7 | 0,2 |
Koersdoel Analisten
Hold
€ 784,38
+37.6%
Low: € 730,00
High: € 830,00
Forward K/W
39,7
Forward WPA
€ 14,56
WPA Groei (sch.)
+0,0%
Omzet Sch.
4,7 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 26,21
€ 25,95 – € 26,56
|
7 B | 6 |
| FY2029 |
€ 21,46
€ 21,24 – € 21,74
|
6,2 B | 6 |
| FY2028 |
€ 18,75
€ 17,56 – € 19,89
|
5,6 B | 8 |
Belangrijkste Punten
Revenue grew 7,56% annually over 5 years — modest growth
Earnings grew 19,33% over the past year
ROE of 66,20% indicates high profitability
Net margin of 24,62% shows strong profitability
Generating 1,05B in free cash flow
P/E of 42,98 — premium valuation
Groei
Revenue Growth (5Y)
7,56%
Revenue (1Y)10,42%
Earnings (1Y)19,33%
FCF Growth (3Y)16,75%
Kwaliteit
Return on Equity
66,20%
ROIC38,02%
Net Margin24,62%
Op. Margin31,60%
Veiligheid
Debt / Equity
0,67
Current Ratio1,17
Interest Coverage35,54
Waardering
P/E Ratio
42,98
P/B Ratio28,36
EV/EBITDA34,14
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 10,42% | Revenue Growth (3Y) | 8,42% |
| Earnings Growth (1Y) | 19,33% | Earnings Growth (3Y) | 11,97% |
| Revenue Growth (5Y) | 7,56% | Earnings Growth (5Y) | 9,21% |
| Profitability | |||
| Revenue (TTM) | 4,30B | Net Income (TTM) | 1,06B |
| ROE | 66,20% | ROA | 31,62% |
| Gross Margin | 61,80% | Operating Margin | 31,60% |
| Net Margin | 24,62% | Free Cash Flow (TTM) | 1,05B |
| ROIC | 38,02% | FCF Growth (3Y) | 16,75% |
| Safety | |||
| Debt / Equity | 0,67 | Current Ratio | 1,17 |
| Interest Coverage | 35,54 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 42,98 | P/B Ratio | 28,36 |
| P/S Ratio | 10,58 | PEG Ratio | 2,30 |
| EV/EBITDA | 34,14 | Dividend Yield | 0,00% |
| Market Cap | 45,53B | Enterprise Value | 46,43B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,30B | 3,90B | 3,66B | 3,37B | 3,22B |
| Net Income | 1,06B | 887,87M | 845,04M | 679,09M | 744,85M |
| EPS (Diluted) | 13,08 | 10,67 | 10,06 | 8,03 | 8,60 |
| Gross Profit | 2,66B | 2,38B | 2,19B | 2,00B | 1,89B |
| Operating Income | 1,36B | 1,13B | 1,10B | 898,77M | 932,03M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,35B | 3,29B | 3,26B | 2,75B | 2,44B |
| Total Liabilities | 1,75B | 1,70B | 1,78B | 2,14B | 1,75B |
| Shareholders' Equity | 1,61B | 1,60B | 1,48B | 608,74M | 689,99M |
| Total Debt | 1,08B | 986,95M | 1,07B | 1,47B | 1,03B |
| Cash & Equivalents | 180,07M | 288,27M | 453,93M | 112,55M | 144,45M |
| Current Assets | 1,34B | 1,40B | 1,50B | 1,10B | 955,66M |
| Current Liabilities | 1,15B | 1,07B | 951,55M | 1,24B | 763,58M |